PerkinElmer
check quantity

AngioSense 680EX Fluorescent Imaging Agent

Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications.

You successfully added item(s) to your cart

For laboratory use only. This product is intended for animal research only and not for use in humans.

Part Number
List Price
Your Price
Quantity
NEV10054EX
601.00 USD
more
Buy Now

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Detail Information

AngioSense® 680 EX reagent is an in vivo blood pool vascular fluorescent imaging agent. AngioSense 680 EX is a near-infrared labeled fluorescent macromolecule that remains localized in the vasculature for extended periods of time and enables imaging of blood vessels and angiogenesis. AngioSense 680 EX can be used to study angiogenesis, as a marker for blood vessel density, in animal tumor models. 

AngioSense 680 EX can be used to characterize vascular changes and therapeutic responses associated with animal models of arthritis. 

Specifications

Fluorescent Agent Type Vascular
Optical Imaging Classification Fluorescence Imaging
Quantity in a Package Amount 1.0 Units
Shipping Condition Blue Ice
Therapeutic Area Vascular disease, Angiogenesis, Arthritis, Inflammation, Oncology/Cancer
Unit Size 1 Vial (10 doses)
Wave Length 680 nm
Resources, Events & More
  • All

Application Note

Vascular Imaging Probes For Oncology and Inflammation Using the IVIS Spectrum

Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. A number of fluorescent imaging probes that circulate with the blood, but have no target selectivity, have been used to detect tumor leakiness as an indication of abnormal tumor vasculature. Inflammation is also characterized by distinct vascular changes, including vasodilation and increased vascular permeability, which are induced by the actions of various inflammatory mediators. This process is essential for facilitating access for appropriate cells, cytokines, and other factors to tissue sites in need of healing or protection from infection. This application note investigates the use of three fluorescent imaging probes, to detect and monitor vascular leak and inflammation in preclinical mouse breast cancer models.

PDF 4 MB

Flyer

Poster

Combined efficacy & toxicity imaging following acute 5-FU treatment of HT-29 tumor xenografts

Cancer chemotherapy can produce severe side effects such as suppression of immune function and damage to heart muscle, gastrointestinal tract, and liver. If serious enough, tissue injury can be a major reason for late stage termination of drug discovery research projects, so it is becoming more important to integrate safety/toxicology assessments earlier in the drug development process. There are a variety of traditional serum markers, tailored mechanistically to specific tissues, however there are no current non-invasive assessment tools that are capable of looking broadly at in situ biological changes in target and non-target tissue induced by chemical insult.

PDF 1 MB

Technical Note

AngioSense 680EX (Data Sheet)

AngioSense® 680 EX is a fluorescent in vivo blood pool imaging agent. AngioSense® 680 EX is a nearinfrared labeled fluorescent macromolecule that remains localized in the vasculature for extended periods of time and enables imaging of blood vessels and angiogenesis.

PDF 229 KB
AngioSense 680EX (Protocol)

AngioSense 680 EX in vivo imaging agent protocol for preparing mice for imaging, preparing AngioSense 680EX agent, injections of agent into mice, imaging injected mice on IVIS and FMT imaging systems

PDF 98 KB